Oliger Christy J.

CIK 00018220929 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001822092

Recent Transactions

45 trades

Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-07-28+38,950→ 38,950 total
Disposition from Tender
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-07-15$124.00/sh−1,324→ 0 total
Disposition to Issuer
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2026-07-15−6,119→ 0 total
Disposition to Issuer
Nuvalent, Inc.$NUVL
Class A Common Stock - Restricted Stock Units
2026-07-15−6,091→ 0 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2026-06-16+3,444→ 7,415 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2026-05-21+17,084→ 17,084 total
Award
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2026-05-21+15,508→ 15,508 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2026-04-01+44,500→ 44,500 total
Disposition to Issuer
LAVA Therapeutics NV
Share Options (Right to Buy)
2025-11-13−33,390→ 0 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2025-06-18+6,119→ 6,119 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-06-18+3,971→ 3,971 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2025-05-28+4,600→ 4,600 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2025-05-14+14,000→ 14,000 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2025-04-01+32,000→ 32,000 total
Award
LAVA Therapeutics NV
Common Shares (Right to Buy)
2025-02-13+33,390→ 33,390 total
Award
Vera Therapeutics, Inc.$VERA
Stock Option (right to buy)
2024-06-07+25,000→ 25,000 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2024-05-29+69,000→ 69,000 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2024-04-01+32,000→ 32,000 total
Disposition to Issuer
RayzeBio, Inc.
Employee Stock Option (Right to Buy)
2024-02-26−114,579→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−106→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−2,137→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,620→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−180→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−5,565→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−1,250→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−10,000→ 0 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-06-07+2,137→ 2,137 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-07$93.61/sh+1,682→ 5,565 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2023-05-24+34,000→ 34,000 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2023-04-01+25,200→ 25,200 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−18,000→ 0 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-06-08$34.76/sh+3,883→ 3,883 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2022-06-08+5,620→ 5,620 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2022-05-19+23,900→ 23,900 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2022-04-01+16,500→ 16,500 total
Award
Replimune Group, Inc.$REPL
Stock Option (right to buy)
2021-12-01+33,000→ 33,000 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-06-10$83.24/sh+180→ 180 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-06-10+5,000→ 5,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2021-06-02+18,000→ 18,000 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2021-05-21+23,900→ 23,900 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15$52.85/sh+106→ 106 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15+10,000→ 10,000 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-04-15+1,250→ 1,250 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2020-08-28+32,800→ 32,800 total

Companies

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov